U-Blot® Research Grade RagistomigCat. No. WA3412Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade RagistomigCat. No. WA3412U-Blot® Research Grade RagifilimabCat. No. WA3411Request quote
Size: 50ug/100ug
U-Blot® Research Grade RafivirumabCat. No. WA3410Request quote
Size: 50ug/100ug
U-Blot® Research Grade RafivirumabCat. No. WA3409Request quote
Size: 50ug/100ug
U-Blot® Research Grade RadretumabCat. No. WA3408Request quote
Size: 50ug/100ug
U-Blot® Research Grade RademikibartCat. No. WA3407Request quote
Size: 50ug/100ug
U-Blot® Research Grade radanstobartCat. No. WA3406Request quote
Size: 50ug/100ug
U-Blot® Research Grade RacotumomabCat. No. WA3405Request quote
Size: 50ug/100ug
U-Blot® Research Grade QuisovalimabCat. No. WA3404Request quote
Size: 50ug/100ug
U-Blot® Research Grade QuilizumabCat. No. WA3403Request quote
Size: 50ug/100ug
U-Blot® Research Grade QuetmolimabCat. No. WA3402Request quote
Size: 50ug/100ug
U-Blot® Research Grade QuavonlimabCat. No. WA3401Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598